Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts

Maria Michela Pallotta,Maddalena Di Nardo,Antonio Musio

DOI: https://doi.org/10.3390/cells13070608

IF: 6

2024-03-31

Cells

Abstract:Cohesin is a highly conserved ring-shaped complex involved in topologically embracing chromatids, gene expression regulation, genome compartmentalization, and genome stability maintenance. Genomic analyses have detected mutations in the cohesin complex in a wide array of human tumors. These findings have led to increased interest in cohesin as a potential target in cancer therapy. Synthetic lethality has been suggested as an approach to exploit genetic differences in cancer cells to influence their selective killing. In this study, we show that mutations in ESCO1, NIPBL, PDS5B, RAD21, SMC1A, SMC3, STAG2, and WAPL genes are synthetically lethal with stimulation of WNT signaling obtained following LY2090314 treatment, a GSK3 inhibitor, in several cancer cell lines. Moreover, treatment led to the stabilization of β-catenin and affected the expression of c-MYC, probably due to the occupancy decrease in cohesin at the c-MYC promoter. Finally, LY2090314 caused gene expression dysregulation mainly involving pathways related to transcription regulation, cell proliferation, and chromatin remodeling. For the first time, our work provides the underlying molecular basis for synthetic lethality due to cohesin mutations and suggests that targeting the WNT may be a promising therapeutic approach for tumors carrying mutated cohesin.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the synthetic lethal relationship between Cohesin and the WNT signaling pathway in the context of multiple cancers. Specifically, the researchers hope to identify cancer cell lines carrying Cohesin gene mutations and analyze the responses of these cell lines to WNT signaling pathway activators (such as LY2090314, a GSK3 inhibitor) to reveal whether these mutations will lead to an increased sensitivity of cells to WNT signal stimulation. In addition, the study also aims to explore the molecular mechanisms behind this synthetic lethal phenomenon, especially the stabilization of β - catenin and its impact on MYC gene expression, thereby providing potential treatment strategies for tumors carrying Cohesin mutations.

The main findings mentioned in the paper include:
- Through whole - exome sequencing (WES), 15 Cohesin gene mutations were detected in nine cell lines in the NCI - 60 cancer cell line panel, and these mutations were mainly concentrated in the core Cohesin genes and regulatory Cohesin genes.
- After being treated with LY2090314, the viability of most cancer cells carrying these mutations decreased significantly, indicating that there is a synthetic lethal relationship between the activation of the WNT signaling pathway and Cohesin mutations.
- Further research shows that LY2090314 treatment leads to the stabilization of β - catenin and affects the expression of MYC, which may be due to the reduced occupation of Cohesin in the MYC promoter region.
- RNA - seq analysis indicates that LY2090314 treatment causes widespread dysregulation of gene expression, mainly affecting pathways such as transcriptional regulation, cell proliferation, and chromatin remodeling.

These results not only reveal the complex interactions between Cohesin mutations and the WNT signaling pathway but also provide a theoretical basis for the development of new therapies for tumors carrying Cohesin mutations.